ANAVEX-1519

N/A

Report date: 2025/01/26 19:06:47
NME

Base Information

Drug NameANAVEX-1519
Drug Alias NameANAVEX-1519
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSigma-2 receptor modulatorsSodium channels modulators
TargetsSigma-2 receptorSodium channels
Therapy Area/IndicationsNeuralgiaOvarian NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnavex Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesAnavex Life Sciences Corp
Inactive CompaniesN/A
Active IndicationsNeuralgiaOvarian Neoplasms
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A